Buscar | Webyourself Social Media Platform

Purvaja Jadhao agregó una foto Other
2023-12-11 12:51:44 -

Digital Healthcare is fastest growing segment fueling the growth of Rivastigmine market
Rivastigmine is a reversible inhibitor of cholinesterase used for the treatment of mild to moderate Alzheimer disease and Parkinsonism. It works by increasing levels of two chemicals, acetylcholine and butyrylcholine, in the brain to help with communication between nerve cells. The global Rivastigmine Market is estimated to be valued at US$ 516.3 Mn in 2023 and is expected to exhibit a CAGR of...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Sushil Sushil agregó una foto Health
2023-09-04 07:38:24 -

Global Rivastigmine Market Is Estimated To Witness High Growth Owing To Increasing Geriatric Population And Rising Prevalence Of Alzheimer's Disease
Market Overview:Rivastigmine is a medication used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. It belongs to the cholinesterase inhibitors class of drugs and is available in the form of oral capsules, oral solutions, and transdermal patches. The market for Rivastigmine is driven by the increasing geriatric population worldwide and the rising prevalence of...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Ashwini Bakhade agregó una foto Other
2024-08-02 12:50:19 -

Rivastigmine Market Poised for Growth Due to Rising Adoption of Novel Drug Delivery Systems
Rivastigmine is primarily used in the treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia symptoms. It helps in improving the symptoms of mental decline by inhibiting the breakdown of acetylcholine, a chemical messenger important for thinking, learning, and memory. The drug is administered orally through capsules or transdermal patches for continuous delivery into...

0 Commentarios 0 Acciones 574 Views 0 Vista previa

Please log in to like, share and comment!